Zanosar Related Published Studies
Well-designed clinical trials related to Zanosar (Streptozocin)
Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. [2005.08.01]
Well-designed clinical trials possibly related to Zanosar (Streptozocin)
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710. [2009.12]
Other research related to Zanosar (Streptozocin)
Chromium, Selenium, and Zinc Multimineral Enriched Yeast Supplementation Ameliorates Diabetes Symptom in Streptozocin-Induced Mice. [2011.11.12]
A single institution experience of streptozocin/fluorouracil combination chemotherapy: a case series. [2011.11.03]
[Effects of electroacupuncture on expression of Abeta positive cells of the hippocampus and SOD activity in rats with streptozocin-Alzheimer's disease]. [2010.12]
Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin-induced diabetic rats. [2010.09]
Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and moderate dose of streptozocin. [2010.05]
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. [2010.03.30]
Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats. [2010]
Adenovirus-mediated decorin gene transfection has therapeutic effects in a streptozocin-induced diabetic rat model. [2010]
In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. [2009.09]
The protective effect of Daming capsule on heart function in streptozocin-induced diabetic rats with hyperlipidemia. [2009.08]
Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. [2009.03]
Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats. [2009.02]
Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: Correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. [2008.11.12]
Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes. [2008.09]
The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. [2008.05.09]
[Influence of Zea mays L. saponin (ZMLS) on ultrastructure of kidney and pancreas in diabetes rats induced by streptozocin] [2008.05]
Cardioprotective effects of grape seed proanthocyanidins extracts in streptozocin induced diabetic rats. [2007.11]
Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats. [2007.07]
Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat. [2007.04.10]
D-chiro-inositol found in Cucurbita ficifolia (Cucurbitaceae) fruit extracts plays the hypoglycaemic role in streptozocin-diabetic rats. [2006.11]
Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. [2006.02.09]
A newly synthesised molybdenum/ascorbic acid complex alleviates some effects of cardiomyopathy in streptozocin-induced diabetic rats. [2006]
Other possibly related research studies
[The expression of insulin signal transduction molecules and islet alpha cell insulin resistance] [2006.09.26]
Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. [2006.09]
New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes. [2006.10]
Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin. [2006.10]
Influence of short-term diabetes on osteocytic lacunae of alveolar bone. A histomorphometric study. [2006]
Controlled release of fibroblast growth factor 2 stimulates bone healing in an animal model of diabetes mellitus. [2006.09]
Oral administration of liposomal insulin. [2006.09]
Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits. [2006.10]
Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro. [2006.12]
Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats. [2006.09]
High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. [2006.10]
Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. [2006.10]
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. [2006.10.03]
Bone associated with implants in diabetic and insulin-treated rats. [2006.10]
Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. [2006.05]
Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. [2006.08]
Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat. [2006.08]
Antihyperglycemic effect of Cucurbita ficifolia fruit extract in streptozotocin-induced diabetic rats. [2006.12]
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. [2006.11]
Inhibitory effect of bucillamine on the increased leukocyte entrapment in the retinal microcirculation of diabetic rats. [2006.07]
Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes. [2006.11.15]
No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy. [2006.10.06]
Treatment of metastatic disease in patients with neuroendocrine tumors. [2006.07]
Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight, and fat stores. [2006.11]
N-hexacosanol reverses diabetic induced muscarinic hypercontractility of ileum in the rat. [2006.09.18]
Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaB. [2006.07.21]
Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats. [2006.08]
The role of hyperglycemia in FAT/CD36 expression and function. [2006.08]
A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats. [2006.06]
Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. [2006.09.27]
Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats. [2006.06.20]
Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. [2006.07]
Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. [2006.05]
Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. [2006.08.01]
Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. [2006.05.20]
Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats. [2005.07]
Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. [2006.06]
Evaluation of the wound healing properties of Acalypha langiana in diabetic rats. [2006.06]
Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. [2006.06.06]
[Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan] [2006.01.24]
Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. [2006.05.07]
Volume-weighted mean volume of the submandibular gland acini in male and female diabetic rats. [2006]
Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. [2006]
Effect of plantain banana on gastric ulceration in NIDDM rats: role of gastric mucosal glycoproteins, cell proliferation, antioxidants and free radicals. [2006.04]
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. [2006.03]
Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1. [2006.05]
Effect of alpha lipoic acid, melatonin and trans resveratrol on intracerebroventricular streptozotocin induced spatial memory deficit in rats. [2005.10]
Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. [2006.06]
Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats. [2006.07.19]
Vitamin C supplementation could reverse diabetes-induced endothelial cell dysfunction in mesenteric microcirculation in STZ-rats. [2006]
Characterization of the antinociceptive effects of oxycodone in diabetic mice. [2006.03.27]
Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats. [2006.06]
In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector. [2006.05.01]
Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment. [2006]
The effect of Aegle marmelos fruit extract in streptozotocin diabetes: a histopathological study. [2005]
Spontaneous motor activity in fat-fed, streptozotocin-treated rats: a nonobese model of type 2 diabetes. [2006.04.15]
Protection of sensory function in diabetic rats by Neotrofin. [2006.03.18]
Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. [2006.03]
Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. [2006.03]
Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. [2006.02]
Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents. [2006.05.15]
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. [2006.03]
The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. [2006.03]
Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats. [2006.06]
Involvement of potassium channels in hypoglycemic effect of sertraline. [2006.02]
Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats. [2006.07]
Antioxidant role of Umbelliferone in STZ-diabetic rats. [2006.06.13]
Impact of umbelliferone on erythrocyte redox status in STZ-diabetic rats. [2005.05]
Expression of chaperonin 60 in the hippocampus of the streptozotocin diabetic rat. [2006.02.27]
Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. [2006.02]
Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. [2006.01]
Effect of high-fat diet and metformin treatment on ventilation and sleep apnea in non-obese rats. [2006.01.25]
Gender disparity of streptozotocin-induced intrinsic contractile dysfunction in murine ventricular myocytes: role of chronic activation of Akt. [2006.01]
Alginate microspheres prepared by internal gelation: development and effect on insulin stability. [2006.03.27]
Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. [2006.03]
Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. [2006.01]
Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. [2006.03]
|
